F2 and autoimmune polyendocrinopathy: Up to 30% of patients with APS may have thrombocytopenia (< 100,000/ mm3), but bleeding is rare and is normally associated with catastrophic APS, immune thrombocytopenia, or patients who produce antibodies against prothrombin or other coagulation factors.42